07:00 - 07:30 PM
Salwa Raafat Azzi

07:00 - 07:30 PM

Diabetes and Technology – An Update on CSII, CGM, and Their Impact on Diabetes Management

Join Salwa Raafat Azzi as she provides an insightful update on the latest advancements in diabetes management, focusing on Continuous Subcutaneous Insulin Infusion (CSII) and Continuous Glucose Monitoring (CGM). Discover how these technologies are transforming diabetes care, enhancing control, and improving patient outcomes.

07:30 - 08:00 PM
Dr. Aly Bernard

Consultant Endocrinologist - Head of Department

Thyroid Nodules – Risk Stratification and Treatment Options

Dr. Aly Bernard discusses the risk stratification and treatment options for thyroid nodules. The focus is on assessing malignancy risk through clinical, imaging, and biopsy methods, followed by tailored treatment approaches ranging from monitoring to surgery, based on individual risk profiles.

08:00 - 08:30 PM
Dr. Mohammed Al Khatib

Consultant Endocrinology

Diabetes Classification – A Review of Updated Guidelines in Management

Dr. Khatib examines the updated guidelines for classifying and managing diabetes. The focus is on the latest diagnostic criteria, treatment strategies, and the importance of tailored approaches to optimize patient care and outcomes.

08:30 - 09:00 PM
Dr. Adriana Rotundo

Consultant Bariatric & General Surgery

Obesity in Diabetes – GLP-1 vs Bariatric Surgery: Who Benefits Most?

Dr. Adriana Rotundo compares GLP-1 receptor agonists and bariatric surgery for obesity management in diabetes. GLP-1 medications are ideal for moderate obesity, offering non-invasive weight loss and improved glycemic control. Bariatric surgery benefits those with severe obesity and complex metabolic issues. Dr. Adriana discusses which patient profiles benefit most from each approach.

09:00 - 09:15 PM
Q&A and Panel Discussion
09:15 PM Onwards
Followed by Dinner